The pharmaceutical industry, it is composed of companies developing and manufacturing innovative medicines and generic pharmaceuticals, as well as over鈥搕he-counter drug products. The sector is made up of a number of sub-sectors that service different market segments.
The global Chemical Drug and Biologic Drug market was valued at US$ 1475000 million in 2023 and is anticipated to reach US$ 2075470 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Chemical Drug and Biologic Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chemical Drug and Biologic Drug.
Report Scope
The Chemical Drug and Biologic Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chemical Drug and Biologic Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chemical Drug and Biologic Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Johnson & Johnson
Novartis
Roche
AbbVie
Merck & Co.
Bristol Myers Squibb
GlaxoSmithKline
Pfizer
Sanofi
Takeda
AstraZeneca
Bayer
Eli Lilly & Co.
Gilead Sciences
Amgen
Novo Nordisk
Teva
Boehringer Ingelheim
Biogen
Astellas
Segment by Type
Chemical Drug
Biologic Drug
Segment by Application
Hospital
Retail Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chemical Drug and Biologic Drug companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Chemical Drug and Biologic Drug 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Chemical Drug
1.2.3 Biologic Drug
1.3 麻豆原创 by Application
1.3.1 Global Chemical Drug and Biologic Drug 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chemical Drug and Biologic Drug 麻豆原创 Perspective (2019-2030)
2.2 Chemical Drug and Biologic Drug Growth Trends by Region
2.2.1 Global Chemical Drug and Biologic Drug 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Chemical Drug and Biologic Drug Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Chemical Drug and Biologic Drug Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Chemical Drug and Biologic Drug 麻豆原创 Dynamics
2.3.1 Chemical Drug and Biologic Drug Industry Trends
2.3.2 Chemical Drug and Biologic Drug 麻豆原创 Drivers
2.3.3 Chemical Drug and Biologic Drug 麻豆原创 Challenges
2.3.4 Chemical Drug and Biologic Drug 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chemical Drug and Biologic Drug Players by Revenue
3.1.1 Global Top Chemical Drug and Biologic Drug Players by Revenue (2019-2024)
3.1.2 Global Chemical Drug and Biologic Drug Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Chemical Drug and Biologic Drug 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chemical Drug and Biologic Drug Revenue
3.4 Global Chemical Drug and Biologic Drug 麻豆原创 Concentration Ratio
3.4.1 Global Chemical Drug and Biologic Drug 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chemical Drug and Biologic Drug Revenue in 2023
3.5 Chemical Drug and Biologic Drug Key Players Head office and Area Served
3.6 Key Players Chemical Drug and Biologic Drug Product Solution and Service
3.7 Date of Enter into Chemical Drug and Biologic Drug 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Chemical Drug and Biologic Drug Breakdown Data by Type
4.1 Global Chemical Drug and Biologic Drug Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Chemical Drug and Biologic Drug Forecasted 麻豆原创 Size by Type (2025-2030)
5 Chemical Drug and Biologic Drug Breakdown Data by Application
5.1 Global Chemical Drug and Biologic Drug Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Chemical Drug and Biologic Drug Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Chemical Drug and Biologic Drug 麻豆原创 Size (2019-2030)
6.2 North America Chemical Drug and Biologic Drug 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Chemical Drug and Biologic Drug 麻豆原创 Size by Country (2019-2024)
6.4 North America Chemical Drug and Biologic Drug 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chemical Drug and Biologic Drug 麻豆原创 Size (2019-2030)
7.2 Europe Chemical Drug and Biologic Drug 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Chemical Drug and Biologic Drug 麻豆原创 Size by Country (2019-2024)
7.4 Europe Chemical Drug and Biologic Drug 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chemical Drug and Biologic Drug 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Chemical Drug and Biologic Drug 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Chemical Drug and Biologic Drug 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Chemical Drug and Biologic Drug 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chemical Drug and Biologic Drug 麻豆原创 Size (2019-2030)
9.2 Latin America Chemical Drug and Biologic Drug 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Chemical Drug and Biologic Drug 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Chemical Drug and Biologic Drug 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chemical Drug and Biologic Drug 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Chemical Drug and Biologic Drug 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Chemical Drug and Biologic Drug 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Chemical Drug and Biologic Drug 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Chemical Drug and Biologic Drug Introduction
11.1.4 Johnson & Johnson Revenue in Chemical Drug and Biologic Drug Business (2019-2024)
11.1.5 Johnson & Johnson Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Chemical Drug and Biologic Drug Introduction
11.2.4 Novartis Revenue in Chemical Drug and Biologic Drug Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Chemical Drug and Biologic Drug Introduction
11.3.4 Roche Revenue in Chemical Drug and Biologic Drug Business (2019-2024)
11.3.5 Roche Recent Development
11.4 AbbVie
11.4.1 AbbVie Company Detail
11.4.2 AbbVie Business Overview
11.4.3 AbbVie Chemical Drug and Biologic Drug Introduction
11.4.4 AbbVie Revenue in Chemical Drug and Biologic Drug Business (2019-2024)
11.4.5 AbbVie Recent Development
11.5 Merck & Co.
11.5.1 Merck & Co. Company Detail
11.5.2 Merck & Co. Business Overview
11.5.3 Merck & Co. Chemical Drug and Biologic Drug Introduction
11.5.4 Merck & Co. Revenue in Chemical Drug and Biologic Drug Business (2019-2024)
11.5.5 Merck & Co. Recent Development
11.6 Bristol Myers Squibb
11.6.1 Bristol Myers Squibb Company Detail
11.6.2 Bristol Myers Squibb Business Overview
11.6.3 Bristol Myers Squibb Chemical Drug and Biologic Drug Introduction
11.6.4 Bristol Myers Squibb Revenue in Chemical Drug and Biologic Drug Business (2019-2024)
11.6.5 Bristol Myers Squibb Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Detail
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Chemical Drug and Biologic Drug Introduction
11.7.4 GlaxoSmithKline Revenue in Chemical Drug and Biologic Drug Business (2019-2024)
11.7.5 GlaxoSmithKline Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Detail
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Chemical Drug and Biologic Drug Introduction
11.8.4 Pfizer Revenue in Chemical Drug and Biologic Drug Business (2019-2024)
11.8.5 Pfizer Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Detail
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Chemical Drug and Biologic Drug Introduction
11.9.4 Sanofi Revenue in Chemical Drug and Biologic Drug Business (2019-2024)
11.9.5 Sanofi Recent Development
11.10 Takeda
11.10.1 Takeda Company Detail
11.10.2 Takeda Business Overview
11.10.3 Takeda Chemical Drug and Biologic Drug Introduction
11.10.4 Takeda Revenue in Chemical Drug and Biologic Drug Business (2019-2024)
11.10.5 Takeda Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Detail
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Chemical Drug and Biologic Drug Introduction
11.11.4 AstraZeneca Revenue in Chemical Drug and Biologic Drug Business (2019-2024)
11.11.5 AstraZeneca Recent Development
11.12 Bayer
11.12.1 Bayer Company Detail
11.12.2 Bayer Business Overview
11.12.3 Bayer Chemical Drug and Biologic Drug Introduction
11.12.4 Bayer Revenue in Chemical Drug and Biologic Drug Business (2019-2024)
11.12.5 Bayer Recent Development
11.13 Eli Lilly & Co.
11.13.1 Eli Lilly & Co. Company Detail
11.13.2 Eli Lilly & Co. Business Overview
11.13.3 Eli Lilly & Co. Chemical Drug and Biologic Drug Introduction
11.13.4 Eli Lilly & Co. Revenue in Chemical Drug and Biologic Drug Business (2019-2024)
11.13.5 Eli Lilly & Co. Recent Development
11.14 Gilead Sciences
11.14.1 Gilead Sciences Company Detail
11.14.2 Gilead Sciences Business Overview
11.14.3 Gilead Sciences Chemical Drug and Biologic Drug Introduction
11.14.4 Gilead Sciences Revenue in Chemical Drug and Biologic Drug Business (2019-2024)
11.14.5 Gilead Sciences Recent Development
11.15 Amgen
11.15.1 Amgen Company Detail
11.15.2 Amgen Business Overview
11.15.3 Amgen Chemical Drug and Biologic Drug Introduction
11.15.4 Amgen Revenue in Chemical Drug and Biologic Drug Business (2019-2024)
11.15.5 Amgen Recent Development
11.16 Novo Nordisk
11.16.1 Novo Nordisk Company Detail
11.16.2 Novo Nordisk Business Overview
11.16.3 Novo Nordisk Chemical Drug and Biologic Drug Introduction
11.16.4 Novo Nordisk Revenue in Chemical Drug and Biologic Drug Business (2019-2024)
11.16.5 Novo Nordisk Recent Development
11.17 Teva
11.17.1 Teva Company Detail
11.17.2 Teva Business Overview
11.17.3 Teva Chemical Drug and Biologic Drug Introduction
11.17.4 Teva Revenue in Chemical Drug and Biologic Drug Business (2019-2024)
11.17.5 Teva Recent Development
11.18 Boehringer Ingelheim
11.18.1 Boehringer Ingelheim Company Detail
11.18.2 Boehringer Ingelheim Business Overview
11.18.3 Boehringer Ingelheim Chemical Drug and Biologic Drug Introduction
11.18.4 Boehringer Ingelheim Revenue in Chemical Drug and Biologic Drug Business (2019-2024)
11.18.5 Boehringer Ingelheim Recent Development
11.19 Biogen
11.19.1 Biogen Company Detail
11.19.2 Biogen Business Overview
11.19.3 Biogen Chemical Drug and Biologic Drug Introduction
11.19.4 Biogen Revenue in Chemical Drug and Biologic Drug Business (2019-2024)
11.19.5 Biogen Recent Development
11.20 Astellas
11.20.1 Astellas Company Detail
11.20.2 Astellas Business Overview
11.20.3 Astellas Chemical Drug and Biologic Drug Introduction
11.20.4 Astellas Revenue in Chemical Drug and Biologic Drug Business (2019-2024)
11.20.5 Astellas Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Johnson & Johnson
Novartis
Roche
AbbVie
Merck & Co.
Bristol Myers Squibb
GlaxoSmithKline
Pfizer
Sanofi
Takeda
AstraZeneca
Bayer
Eli Lilly & Co.
Gilead Sciences
Amgen
Novo Nordisk
Teva
Boehringer Ingelheim
Biogen
Astellas
听
听
*If Applicable.